DIA, New York, NY
Feb 23 2010 8:00AM - Feb 24 2010 5:00PM
This annual must-attend conference will provide valuable insight into the evolution of the regulatory and legal environment and how this new environment impacts the marketing of biopharmaceuticals and related products. Featured Topics · Enforcement by the three centers within FDA that regulate drugs, biological products and veterinary drugs · Direct-to-consumer advertising · State regulations · Oversight of off-label issues by the Office of Inspector General and Department of Justice · Latest innovations in the use of the internet for product communication
Learning Objectives:
At the conclusion of this conference, participants should be able to: · Identify the trends reflected in the latest enforcement actions and policies by the FDA · Summarize best practices by other companies in implementing regulatory policies · Describe how companies can best navigate the regulatory review process at FDA · Outline the policies and actions being taken by others, such as OIG, DOJ and trade and professional associations
Target Audience:
Professionals who are new to pharmaceutical advertising and promotion as well as those who have been involved in this area for some time, including professionals from: · Marketing · Legal/Regulatory affairs · Public relations/Advertising · Marketing communications · Compliance and management in pharmaceutical, veterinary medicine, biologics and medical device companies and organizations
|